22-Oct-2021 | Zion Market Research
Major companies in Construction Sealant Market are the Intuitive Surgical, Medical Devices Business Services, Inc., Olympus Corporation, AngioDynamics, Scanlan International, KARL STORZ SE & Co. KG, TROKAMED GmbH, F.Hoffmann-La Roche Ltd., Pfizer Inc., Abbott, Boehringer Ingelheim International GmbH, Genentech Inc., Boston Scientific Corporation, among others. These players are set to bolster the development of global Lung Cancer Surgery market.
According to analysts at Zion Market Research, the global Lung Cancer Surgery market accounted for more than USD 5.63 Billion in 2020 and is expected to reach USD 7.59 Billion by 2028, growing at a CAGR of 4.2% from 2021 to 2028.
This review is based on a report by Zion Market Research, titled “Lung Cancer Surgery Market By Type (Surgical Instruments, Monitoring & Visualizing Systems, and Endosurgical Equipment), By Procedure (Robotic Surgery, Thoracotomy, Lobectomy, Sleeve Resection, Endobronchial Surgery, Pneumonectomy, Percutaneous Surgery, Segmentectomy, and Minimally Invasive Surgeries), By Treatment (Hospitals, Clinics, Ambulatory Surgical Centers, and Research Laboratories): Global Industry Perspective, Comprehensive Analysis and Forecast, 2021 – 2028.”
Smoking trend among women, rising retiree population To Spur Growth
Cancer is the second largest leading cause of death globally, accounting for millions of deaths. The rising cancer incidence globally also signify the rising trend for lung cancer prevalence worldwide. This scenario represented by a favourable environment of funding and treatment options to cure, the increasing prevalence and incidence of cancer are anticipated to bolster the tally of patients opting for treatment for lung cancer surgery in the forecast period. This, in turn, is anticipated to fuel the growth of the industry in the forecast period.
Presence of big players to Support North America Dominance
North America held largest share in the market. This is attributable to increasing technological advancements in treatment of lung cancer, rising prevalence and incidence of lung cancer, Growing trend of tobacco smoking, rising emphasis on treatment & early diagnosis of cancers, and availability of reimbursement.
Browse the full “Lung Cancer Surgery Market By Type (Surgical Instruments, Monitoring & Visualizing Systems, and Endosurgical Equipment), By Procedure (Robotic Surgery, Thoracotomy, Lobectomy, Sleeve Resection, Endobronchial Surgery, Pneumonectomy, Percutaneous Surgery, Segmentectomy, and Minimally Invasive Surgeries), By Treatment (Hospitals, Clinics, Ambulatory Surgical Centers, and Research Laboratories): Global Industry Perspective, Comprehensive Analysis and Forecast, 2021 – 2028.” Report at https://www.zionmarketresearch.com/report/lung-cancer-surgery-market
Asia Pacific Lung surgery market is expected to rise on account of increasing favourable initiatives by government, increasing occurrence of lung cancer, and growing healthcare expenditure.
The Lung Cancer Surgery market is segmented as follows:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651